Page last updated: 2024-08-26

tandospirone and Dementia

tandospirone has been researched along with Dementia in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akagawa, Y; Hishikawa, Y; Masuda, Y1
Inada, K; Ishigooka, J1
Asada, T; Mizukami, K; Sato, S1
Esumi, E; Kojima, S; Maruka, Y1

Reviews

1 review(s) available for tandospirone and Dementia

ArticleYear
[Dementia induced by antianxiety drugs].
    Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl

    Topics: Aging; Anti-Anxiety Agents; Benzodiazepines; Chlorides; Dementia; GABA-A Receptor Agonists; gamma-Aminobutyric Acid; Half-Life; Humans; Isoindoles; Memory Disorders; Piperazines; Pyrimidines; Risk Factors; Serotonin Receptor Agonists

2004

Trials

2 trial(s) available for tandospirone and Dementia

ArticleYear
Effect of serotonin 1A agonist tandospirone on depression symptoms in senile patients with dementia.
    Human psychopharmacology, 2002, Volume: 17, Issue:4

    Topics: Aged; Aged, 80 and over; Dementia; Depression; Humans; Isoindoles; Piperazines; Psychiatric Status Rating Scales; Pyrimidines; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin Receptor Agonists; Time Factors; Treatment Outcome

2002
A preliminary open-label study of 5-HT1A partial agonist tandospirone for behavioural and psychological symptoms associated with dementia.
    The international journal of neuropsychopharmacology, 2007, Volume: 10, Issue:2

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Behavior; Dementia; Dementia, Vascular; Dose-Response Relationship, Drug; Female; Humans; Isoindoles; Male; Neuropsychological Tests; Pilot Projects; Piperazines; Psychiatric Status Rating Scales; Pyrimidines; Receptor, Serotonin, 5-HT1A; Serotonin Receptor Agonists

2007

Other Studies

1 other study(ies) available for tandospirone and Dementia

ArticleYear
Tandospirone, a promising alternative drug in the treatment of chorea.
    Internal medicine (Tokyo, Japan), 2000, Volume: 39, Issue:12

    Topics: Animals; Atrophy; Cerebral Cortex; Chorea; Dementia; Dopamine Antagonists; Female; Fluvoxamine; Haloperidol; Humans; Isoindoles; Mice; Mice, Neurologic Mutants; Mice, Transgenic; Middle Aged; Piperazines; Pyrimidines; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Trinucleotide Repeat Expansion

2000